Panagiotis Athanassiou

Thessaloniki, ESYE12 55134, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Psoriatic Arthritis: Therapeutic Advances and Novel Treatment Strategies-A Scoping Review.

Psoriatic Arthritis: Therapeutic Advances and Novel Treatment Strategies-A Scoping Review.

Journal: Life (Basel, Switzerland)

Published: March 31, 2026

Euthyroid Sick Syndrome as an Index of Prognosis in Severe COVID-19 Disease.

Euthyroid Sick Syndrome as an Index of Prognosis in Severe COVID-19 Disease.

Journal: Medicina (Kaunas, Lithuania)

Published: June 09, 2025

Targeted Cellular Treatment of Systemic Lupus Erythematosus.

Targeted Cellular Treatment of Systemic Lupus Erythematosus.

Journal: Cells

Published: December 23, 2024

Editorial: Anti-inflammatory diet in autoimmune diseases.

Editorial: Anti-inflammatory diet in autoimmune diseases.

Journal: Frontiers in nutrition

Published: September 16, 2024

Osteoporosis in a Woman With Multiple Sclerosis: A Case Report.

Osteoporosis in a Woman With Multiple Sclerosis: A Case Report.

Journal: Cureus

Published: April 29, 2024

Vitamin D Levels as a Marker of Severe SARS-CoV-2 Infection.

Vitamin D Levels as a Marker of Severe SARS-CoV-2 Infection.

Journal: Life (Basel, Switzerland)

Published: December 22, 2023

Editorial: (Osteo)sarcopenia & sarcopenic obesity, volume II.

Editorial: (Osteo)sarcopenia & sarcopenic obesity, volume II.

Journal: Frontiers in endocrinology

Published: October 08, 2023

Thyroid Disease and Systemic Lupus Erythematosus.

Thyroid Disease and Systemic Lupus Erythematosus.

Journal: Medicina (Kaunas, Lithuania)

Published: September 30, 2023

Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study): a multicenter, post-marketing, non-interventional, observational trial.

Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study): a multicenter, post-marketing, non-interventional, observational trial.

Journal: Clinical rheumatology

Published: August 01, 2023

Current Treatment Approach, Emerging Therapies and New Horizons in Systemic Lupus Erythematosus.

Current Treatment Approach, Emerging Therapies and New Horizons in Systemic Lupus Erythematosus.

Journal: Life (Basel, Switzerland)

Published: June 06, 2023

Real-world effectiveness of golimumab in adult patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis and an inadequate response to initial TNFi therapy in Greece: the GO-BEYOND prospective, observational study.

Real-world effectiveness of golimumab in adult patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis and an inadequate response to initial TNFi therapy in Greece: the GO-BEYOND prospective, observational study.

Journal: Rheumatology international

Published: April 10, 2023

Vitamin D Deficiency in Primary Sjögren's Syndrome: Association with Clinical Manifestations and Immune Activation Markers.

Vitamin D Deficiency in Primary Sjögren's Syndrome: Association with Clinical Manifestations and Immune Activation Markers.

Journal: Mediterranean journal of rheumatology

Published: March 21, 2022

Showing 1-12 of 28

Last Updated: 09/26/2026